The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

26 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
9
Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors.EBI
F. Hoffmann-La Roche
10
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.EBI
Chinese Academy of Sciences
1
Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.EBI
University of Minnesota
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.EBI
Johann Wolfgang Goethe University
36
Recent Advances on Small-Molecule Inhibitors of Lipocalin-like Proteins.EBI
Sichuan University
21
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).EBI
Bristol Myers Squibb
17
Truxillic acid monoamides as fatty acid binding protein 5 inhibitors.EBI
Stony Brook University
87
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review.EBI
Universita degli Studi di Catania
19
A Real-World Perspective on Molecular Design.EBI
F. Hoffmann-La Roche
5
NMR structure of a potent small molecule inhibitor bound to human keratinocyte fatty acid-binding protein.EBI
Bristol Myers Squibb
8
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022.EBI
University of Catania
28
Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.EBI
Biovitrum
27
Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus.EBI
Fudan University
21
Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation.EBI
Chinese Academy of Sciences
31
Plant-Based Modulators of Endocannabinoid Signaling.EBI
Concordia University Wisconsin
26
Identification of new dual FABP4/5 inhibitors based on a naphthalene-1-sulfonamide FABP4 inhibitor.EBI
Fudan University
46
SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.EBI
Stony Brook University
19
Compounds useful for inhibiting RAF dimersBDB
Albert Einstein College of Medicine
13
Substituted pyrimidinones as agonists of the APJ receptorBDB
Amgen
66
Farnesoid X receptor agonists and uses thereofBDB
Metacrine
19
Synthesis, ß-glucuronidase inhibition and molecular docking studies of hybrid bisindole-thiosemicarbazides analogs.BDB
Universiti Teknologi Mara
7
Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereofBDB
Bayer Intellectual Property
17
Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetesBDB
Merck Sharp & Dohme
11
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.BDB
University of Massachusetts
119
Inhibitors of JAKBDB
Hoffmann-La Roche
6
Botryllamides and method of inhibiting PGP in a mammal afflicted with cancerBDB
Department Of Health And Human Services